| Year |
Citation |
Score |
| 2020 |
Tichy EM, Schumock GT, Hoffman JM, Suda KJ, Rim MH, Tadrous M, Stubbings J, Cuellar S, Clark JS, Wiest MD, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2020. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 32412055 DOI: 10.1093/Ajhp/Zxaa116 |
0.37 |
|
| 2020 |
Sharma D, Schumock GT, Saffore CD, Albert Edwards S, Walton SM. Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales. Therapeutic Innovation & Regulatory Science. 54: 424-430. PMID 32072591 DOI: 10.1007/S43441-019-00072-8 |
0.333 |
|
| 2019 |
Patel H, Calip GS, DiDomenico RJ, Schumock GT, Suda KJ, Lee TA. Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin Before and After the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms. Pharmacotherapy. PMID 31867748 DOI: 10.1002/Phar.2355 |
0.306 |
|
| 2019 |
Schumock GT, Stubbings J, Hoffman JM, Wiest MD, Suda KJ, Rim MH, Tadrous M, Tichy EM, Cuellar S, Clark JS, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2019. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 31199861 DOI: 10.1093/Ajhp/Zxz109 |
0.362 |
|
| 2018 |
Hong SJ, Li EC, Matusiak LM, Schumock GT. Spending on Antineoplastic Agents in the United States, 2011 to 2016. Journal of Oncology Practice. JOP1800069. PMID 30226791 DOI: 10.1200/Jop.18.00069 |
0.321 |
|
| 2018 |
Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT. Risk of Amputations Associated with SGLT2 Inhibitors Compared to DPP-4 Inhibitors: A Propensity-Matched Cohort Study. Diabetes, Obesity & Metabolism. PMID 29971914 DOI: 10.1111/Dom.13459 |
0.303 |
|
| 2018 |
Schumock GT, Stubbings J, Wiest MD, Li EC, Suda KJ, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2018. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 29748254 DOI: 10.2146/Ajhp180138 |
0.362 |
|
| 2017 |
Schumock GT, Li EC, Wiest MD, Suda KJ, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2017. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 28533252 DOI: 10.2146/Ajhp170164 |
0.362 |
|
| 2017 |
Sharma D, Schumock G, Saffore C, Walton S. Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures Value in Health. 20: A655. DOI: 10.1016/J.Jval.2017.08.1555 |
0.323 |
|
| 2016 |
Schumock GT, Vermeulen LC. The Rising Cost of Prescription Drugs: Causes and Solutions. Pharmacotherapy. PMID 27943363 DOI: 10.1002/Phar.1873 |
0.31 |
|
| 2016 |
Schumock GT, Li EC, Suda KJ, Wiest MD, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2016. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. PMID 27170624 DOI: 10.2146/Ajhp160205 |
0.362 |
|
| 2015 |
Suda KJ, Hunkler RJ, Matusiak LM, Schumock GT. Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003-2012. Pharmacotherapy. 35: 991-7. PMID 26598091 DOI: 10.1002/Phar.1656 |
0.311 |
|
| 2015 |
Hartke PL, Vermeulen LC, Hoffman JM, Shah ND, Doloresco F, Suda KJ, Li EC, Matusiak LM, Hunkler RJ, Schumock GT. Accuracy of annual prescription drug expenditure forecasts in AJHP. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 72: 1642-8. PMID 26386105 DOI: 10.2146/Ajhp140850 |
0.35 |
|
| 2015 |
Schumock GT, Li EC, Suda KJ, Wiest MD, Stubbings J, Matusiak LM, Hunkler RJ, Vermeulen LC. National trends in prescription drug expenditures and projections for 2015. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 72: 717-36. PMID 25873620 DOI: 10.2146/Ajhp140849 |
0.392 |
|
| 2014 |
Walton SM, Schumock GT. Should off-label drugs be included as comparators in pharmacoeconomic studies? Pharmacoeconomics. 32: 1035-7. PMID 25270597 DOI: 10.1007/S40273-014-0222-2 |
0.321 |
|
| 2014 |
Lee WJ, Lee TA, Pickard AS, Caskey RN, Schumock GT. Drugs associated with adverse events in children and adolescents. Pharmacotherapy. 34: 918-26. PMID 24990656 DOI: 10.1002/Phar.1455 |
0.312 |
|
| 2014 |
Schumock GT, Li EC, Suda KJ, Matusiak LM, Hunkler RJ, Vermeulen LC, Hoffman JM. National trends in prescription drug expenditures and projections for 2014. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 71: 482-99. PMID 24589540 DOI: 10.2146/Ajhp130767 |
0.359 |
|
| 2013 |
Hoffman JM, Li E, Doloresco F, Matusiak L, Hunkler RJ, Shah ND, Vermeulen LC, Schumock GT. Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 70: 525-39. PMID 23456407 DOI: 10.2146/Ajhp120759 |
0.367 |
|
| 2013 |
Lee WJ, Schumock GT, Lee TA. Drugs Associated With Adverse Drug Events In Children: Analysis Of The United States Fda Adverse Event Reporting System Database Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.311 |
0.32 |
|
| 2012 |
Touchette DR, Masica AL, Dolor RJ, Schumock GT, Choi YK, Kim Y, Smith SR. Safety-focused medication therapy management: a randomized controlled trial. Journal of the American Pharmacists Association : Japha. 52: 603-12. PMID 23023840 DOI: 10.1331/Japha.2012.12036 |
0.332 |
|
| 2012 |
Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA. Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study. The Journal of Allergy and Clinical Immunology. 130: 368-75. PMID 22698520 DOI: 10.1016/J.Jaci.2012.04.035 |
0.543 |
|
| 2012 |
Samp JC, Schumock GT, Pickard AS. Retracted publications in the drug literature. Pharmacotherapy. 32: 586-95. PMID 22581659 DOI: 10.1002/J.1875-9114.2012.01100.X |
0.302 |
|
| 2012 |
Hoffman JM, Li E, Doloresco F, Matusiak L, Hunkler RJ, Shah ND, Vermeulen LC, Schumock GT. Projecting future drug expenditures--2012. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 69: 405-21. PMID 22345420 DOI: 10.2146/Ajhp110697 |
0.328 |
|
| 2012 |
Stein BD, Bautista A, Schumock GT, Lee TA, Charbeneau JT, Lauderdale DS, Naureckas ET, Meltzer DO, Krishnan JA. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 141: 87-93. PMID 21757568 DOI: 10.1378/Chest.11-0024 |
0.311 |
|
| 2012 |
Schumock GT, Gibbons RD, Lee TA, Joo MJ, Stayner LT, Valuck RJ. The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide Drug Information Journal. 46: 99-106. DOI: 10.1177/0092861511427856 |
0.561 |
|
| 2011 |
Nutescu EA, Bathija S, Sharp LK, Gerber BS, Schumock GT, Fitzgibbon ML. Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption. Pharmacotherapy. 31: 1161-74. PMID 22122179 DOI: 10.1592/Phco.31.12.1161 |
0.306 |
|
| 2011 |
Schumock GT, Gibbons RD, Lee TA, Joo MJ, Valuck RJ, Stayner LT. Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US. Drug, Healthcare and Patient Safety. 3: 47-52. PMID 22046105 DOI: 10.2147/Dhps.S23665 |
0.549 |
|
| 2011 |
Tiryaki F, Nutescu EA, Hennenfent JA, Karageanes AM, Koesterer LJ, Lambert BL, Schumock GT. Anticoagulation therapy for hospitalized patients: patterns of use, compliance with national guidelines, and performance on quality measures. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 68: 1239-44. PMID 21690430 DOI: 10.2146/Ajhp100543 |
0.369 |
|
| 2011 |
Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Safety. 34: 533-44. PMID 21663330 DOI: 10.2165/11587260-000000000-00000 |
0.56 |
|
| 2011 |
Doloresco F, Fominaya C, Schumock GT, Vermeulen LC, Matusiak L, Hunkler RJ, Shah ND, Hoffman JM. Projecting future drug expenditures: 2011. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 68: 921-32. PMID 21546644 DOI: 10.2146/Ajhp100712 |
0.378 |
|
| 2010 |
Yang Y, McBride MV, Rodvold KA, Tverdek F, Trese AM, Hennenfent J, Schiff G, Lambert BL, Schumock GT. Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 67: 1017-24. PMID 20516473 DOI: 10.2146/Ajhp090563 |
0.305 |
|
| 2010 |
Stein BD, Charbeneau JT, Lee TA, Schumock GT, Lindenauer PK, Bautista A, Lauderdale DS, Naureckas ET, Krishnan JA. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. Copd. 7: 164-71. PMID 20486814 DOI: 10.3109/15412555.2010.481696 |
0.317 |
|
| 2010 |
Hoffman JM, Doloresco F, Vermeulen LC, Shah ND, Matusiak L, Hunkler RJ, Schumock GT. Projecting future drug expenditures--2010. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 67: 919-28. PMID 20484216 DOI: 10.2146/Ajhp100068 |
0.328 |
|
| 2010 |
Walton SM, Schumock GT, Alexander GC, Meltzer D, Stafford RS. Importance of distinguishing supported and unsupported off-label drug use. Archives of Internal Medicine. 170: 657-8; author reply . PMID 20386014 DOI: 10.1001/Archinternmed.2010.69 |
0.307 |
|
| 2009 |
Anderson SV, Schumock GT. Evaluation and justification of clinical pharmacy services. Expert Review of Pharmacoeconomics & Outcomes Research. 9: 539-45. PMID 19941431 DOI: 10.1586/Erp.09.57 |
0.329 |
|
| 2009 |
Schumock GT, Pickard AS. Comparative effectiveness research: Relevance and applications to pharmacy. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 66: 1278-86. PMID 19574602 DOI: 10.2146/Ajhp090150 |
0.338 |
|
| 2009 |
Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Martin PK, Blake S, Matusiak L, Hunkler RJ, Schumock GT. Projecting future drug expenditures--2009. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 66: 237-57. PMID 19179637 DOI: 10.2146/Ajhp080636 |
0.328 |
|
| 2008 |
Didomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT. Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure. The Annals of Pharmacotherapy. 42: 327-33. PMID 18303142 DOI: 10.1345/Aph.1K496 |
0.337 |
|
| 2008 |
Pickard AS, Becker RC, Schumock GT, Frye CB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy. 28: 376-92. PMID 18294117 DOI: 10.1592/Phco.28.3.376 |
0.319 |
|
| 2008 |
Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Grim P, Hunkler RJ, Hontz KM, Schumock GT. Projecting future drug expenditures--2008. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 65: 234-53. PMID 18216009 DOI: 10.2146/Ajhp070629 |
0.329 |
|
| 2007 |
Vats V, Nutescu EA, Theobald JC, Wojtynek JE, Schumock GT. Survey of hospitals for guidelines, policies, and protocols for anticoagulants. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 64: 1203-8. PMID 17519463 DOI: 10.2146/Ajhp060264 |
0.305 |
|
| 2007 |
Gupta SR, Wojtynek JE, Walton SM, Botticelli JT, Shields KL, Quad JE, Schumock GT. Association between hospital size and pharmacy department productivity. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 64: 937-44. PMID 17468148 DOI: 10.2146/Ajhp060228 |
0.301 |
|
| 2007 |
Hoffman JM, Shah ND, Vermeulen LC, Schumock GT, Grim P, Hunkler RJ, Hontz KM. Projecting future drug expenditures--2007. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 64: 298-314. PMID 17244880 DOI: 10.2146/Ajhp060545 |
0.339 |
|
| 2007 |
Schumock GT, Arruda JAL, Marx SE, Melnick J, Sterz R, Williams LA. Pharmacoeconomic analysis of paricalcitol and calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis: impact of hospitalisations and survival Journal of Medical Economics. 10: 393-409. DOI: 10.3111/13696990701646619 |
0.302 |
|
| 2006 |
Hoffman JM, Shah ND, Vermeulen LC, Schumock GT, Grim P, Hunkler RJ, Hontz KM. Projecting future drug expenditures--2006. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 63: 123-38. PMID 16390926 DOI: 10.2146/Ajhp050446 |
0.339 |
|
| 2006 |
Vats V, Nutescu EA, Blackburn JC, Ansell JE, Wittkowsky AK, Shapiro NL, Schumock GT. Quality of Warfarin Management in Anticoagulation Clinics in the U.S. Blood. 108: 627-627. DOI: 10.1182/Blood.V108.11.627.627 |
0.317 |
|
| 2005 |
McKoy JM, Lyons EA, Obadina E, Carson K, Pickard AS, Schellhammer P, McLeod D, Boyd CE, McWilliams N, Sartor O, Schumock GT, McCaffery K, Bennett CL. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8894-905. PMID 16314650 DOI: 10.1200/Jco.2005.01.4605 |
0.316 |
|
| 2005 |
Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell EF, McCaffrey KR, Bennett CL. Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited. Pharmacoeconomics. 23: 767-75. PMID 16097839 DOI: 10.2165/00019053-200523080-00003 |
0.311 |
|
| 2005 |
Nutescu EA, Park HY, Walton SM, Blackburn JC, Finley JM, Lewis RK, Schumock GT. Factors that influence prescribing within a therapeutic drug class. Journal of Evaluation in Clinical Practice. 11: 357-65. PMID 16011648 DOI: 10.1111/J.1365-2753.2005.00545.X |
0.334 |
|
| 2005 |
Stubbings J, Kliethermes MA, Schumock GT. Medicare drug cards: where are the savings? Journal of the American Pharmacists Association : Japha. 45: 308, 311. PMID 15991751 DOI: 10.1331/1544345054003769 |
0.335 |
|
| 2005 |
Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, et al. The Research on Adverse Drug Events and Reports (RADAR) project. Jama. 293: 2131-40. PMID 15870417 DOI: 10.1001/Jama.293.17.2131 |
0.328 |
|
| 2005 |
Carson KR, McCaffrey KR, Sharma R, Okano GJ, Argiris A, Pickard AS, Schumock GT, Bennett CL. Costs of hospitalization for head and neck (HNC) or non-small cell lung cancer (NSCLC) patients (Pts) with oral mucositis (OM) and/or esophagitis who undergo radiochemotherapy Journal of Clinical Oncology. 23: 8089-8089. DOI: 10.1200/Jco.2005.23.16_Suppl.8089 |
0.341 |
|
| 2004 |
Pickard AS, Nau DP, McKercher PL, Schumock GT. Importation of prescription medications: experiences, opinions, and intended behaviors of U.S. community pharmacists. Journal of the American Pharmacists Association : Japha. 44: 666-72. PMID 15637849 DOI: 10.1331/1544345042467218 |
0.362 |
|
| 2004 |
Nutescu EA, Pickard AS, Blackburn JC, Wittkowsky AK, Ansell J, Schumock GT. Impact of oral direct thrombin inhibitors on anticoagulation clinics. Pharmacotherapy. 24: 1204-12. PMID 15460181 DOI: 10.1592/Phco.24.13.1204.38093 |
0.305 |
|
| 2004 |
Schumock GT, Blackburn JC, Nutescu EA, Walton SM, Finley JM, Lewis RK. Impact of prescribing guidelines for inpatient anticoagulation. The Annals of Pharmacotherapy. 38: 1570-5. PMID 15304628 DOI: 10.1345/Aph.1E121 |
0.367 |
|
| 2004 |
Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM, Lewis RK. Factors that influence prescribing decisions. The Annals of Pharmacotherapy. 38: 557-62. PMID 14966259 DOI: 10.1345/Aph.1D390 |
0.353 |
|
| 2004 |
Chacko R, Klinge SA, Luminari S, Fotis M, McKoy J, Belknap SM, Raisch DW, Schumock G, Tallman MS, Bennett CL. Completeness and effectiveness of reporting on three drugs: Lessons learned from RADAR, a novel pharmacosurveillance and pharmacovigilance program Journal of Clinical Oncology. 22: 3201-3201. DOI: 10.1200/Jco.2004.22.90140.3201 |
0.322 |
|
| 2003 |
Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3859-66. PMID 14551305 DOI: 10.1200/Jco.2003.04.537 |
0.357 |
|
| 2003 |
Schumock G, Walton S, Sarawate C, Crawford SY. Pharmaceutical services in rural hospitals in Illinois--2001. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 60: 666-74. PMID 12701548 DOI: 10.1093/Ajhp/60.7.666 |
0.34 |
|
| 2003 |
Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 23: 113-32. PMID 12523470 DOI: 10.1592/Phco.23.1.113.31910 |
0.318 |
|
| 2002 |
Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. Thalidomide-associated deep vein thrombosis and pulmonary embolism. The American Journal of Medicine. 113: 603-6. PMID 12459408 DOI: 10.1016/S0002-9343(02)01300-1 |
0.336 |
|
| 2002 |
Schumock GT, Nutescu EA, Walton SM, Arondekar BV, Lewis RK. Survey of hospital policies regarding low-molecular-weight heparins. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 59: 534-8. PMID 11908246 DOI: 10.1093/Ajhp/59.6.534 |
0.322 |
|
| 2001 |
Walton S, Johnson N, Arondekar B, Schumock G. PHP18: A MODEL FOR COMPARING COSTS ASSOCIATED WITH PRESCRIPTION WASTAGE WITH APPLICATION TO VA PRESCRIPTION DATA Value in Health. 4: 175. DOI: 10.1046/J.1524-4733.2001.40202-278.X |
0.316 |
|
| 2001 |
Goldstein JL, Larson LR, Yamashita BD, Fain JM, Schumock GT. Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study The American Journal of Gastroenterology. 96: 2360-2366. DOI: 10.1016/S0002-9270(01)02609-0 |
0.347 |
|
| 2000 |
Schumock GT. Methods to assess the humanistic outcomes of clinical pharmacy services. Pharmacotherapy. 20. PMID 11034051 DOI: 10.1592/Phco.20.16.253S.35010 |
0.306 |
|
| 1999 |
Schumock GT, Michaud J, Guenette AJ. Re-engineering: an opportunity to advance clinical practice in a community hospital. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 56: 1945-9. PMID 10554912 DOI: 10.1093/Ajhp/56.19.1945 |
0.321 |
|
| 1998 |
Seeger JD, Kong SX, Schumock GT. Characteristics Associated with Ability to Prevent Adverse Drug Reactions in Hospitalized Patients Pharmacotherapy. 18: 1284-1289. DOI: 10.1002/J.1875-9114.1998.Tb03149.X |
0.37 |
|
| 1996 |
Schumock GT, Lam NP, Winkler SR, Kong SX. Pharmacoeconomic Analysis of Stress Ulcer Prophylaxis for Critically Ill Patients Pharmacoeconomics. 9: 455-465. PMID 10160257 DOI: 10.2165/00019053-199609050-00008 |
0.307 |
|
| 1996 |
Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic Evaluations of Clinical Pharmacy Services—1988–1995 Pharmacotherapy. 16: 1188-1208. DOI: 10.1002/J.1875-9114.1996.Tb03049.X |
0.311 |
|
| 1992 |
Schumock GT, Manasse HR, Hutchinson RA. Pharmaceutical services in rural hospitals in Illinois--1991. American Journal of Health-System Pharmacy. 49: 2187-2192. DOI: 10.1093/Ajhp/49.9.2187 |
0.344 |
|
| 1991 |
Schumock GT, Thornton JP, Witte KW. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. American Journal of Health-System Pharmacy. 48: 1974-1976. DOI: 10.1093/Ajhp/48.9.1974 |
0.315 |
|
| 1990 |
Schumock G, Witte K. Less expensive is not always less effective. Jama Internal Medicine. 150: 2420-2420. DOI: 10.1001/Archinte.1990.00390220146044 |
0.351 |
|
| Show low-probability matches. |